Stockreport

Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

Precipio, Inc.  (PRPO) 
US:NASDAQ Investor Relations: precipiodx.com/investors.html
PDF NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has announced the publication1 in the Journal o [Read more]